Stockscreener 앱 받기
0.3544
1.50%
-0.0054
시장 영업 전:
.36
0.0056
+1.58%
전일 마감가:
$0.3598
열려 있는:
$0.36
하루 거래량:
182.76K
Relative Volume:
0.04
시가총액:
$1.65M
수익:
$75,000
순이익/손실:
$-42.41M
주가수익비율:
-0.00197
EPS:
-179.8206
순현금흐름:
$-18.47M
1주 성능:
-5.79%
1개월 성능:
-34.54%
6개월 성능:
-97.21%
1년 성능:
+0.00%
1일 변동 폭
$0.345
$0.365
1주일 범위
$0.3431
$0.39
52주 변동 폭
$0.3431
$166.50
Profusa Inc Stock (PFSA) Company Profile
명칭
Profusa Inc
전화
212-494-9022
주소
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.3544 | 1.68M | 75,000 | -42.41M | -18.47M | -179.82 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profusa Inc 주식(PFSA)의 최신 뉴스
Profusa Shares Below 40 Cents as Nasdaq Deadline Nears - Bez Kabli
PFSA Stock Chart | PROFUSA INC (NASDAQ:PFSA) - ChartMill
PFSA | Profusa, Inc. Common Stock Executive Compensation - Quiver Quantitative
[ARS] Profusa, Inc. SEC Filing - Stock Titan
Profusa (NASDAQ: PFSA) eyes major reverse split, $30M PanOmics stock acquisition and note conversion - Stock Titan
Profusa Amends $30 Million Asset Purchase of PanOmics Assay, Drops 12% Management Equity Grant - TradingView
[8-K] Profusa, Inc. Reports Material Event - Stock Titan
PFSA Should I Buy - Intellectia AI
Profusa, Inc. Submits Advance Notice for Equity Line Share Purchase with Ascent Partners Fund LLC – SEC Filing 8-K May 18, 2026 - Minichart
Profusa submits equity purchase notice to Ascent Partners under credit agreement - Investing.com Nigeria
Profusa (NASDAQ: PFSA) registers 179.3M resale shares; Ascent equity line terms detailed - Stock Titan
Profusa Taps Equity Line for Near-Term Liquidity - TipRanks
Profusa submits advance notice to Ascent for up to 9.99% equity purchase with true-up mechanism - TradingView
Profusa (NASDAQ: PFSA) details May equity line share purchase terms - Stock Titan
Number of shareholders of Profusa, Inc. – NASDAQ:PFSA - TradingView
Profusa Transfers Nasdaq Listing Amid Ongoing Compliance Uncertainty - The Globe and Mail
PFSA Financials: Income Statement, Balance Sheet & Cash Flow | Profusa Inc - Stock Titan
Profusa, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Profusa (NASDAQ: PFSA) Q1 2026 loss deepens amid going concern and Nasdaq listing pressure - Stock Titan
Profusa, Inc. Announces Transfer to Nasdaq Capital Market to Ensure Continued Listing Compliance - Minichart
Profusa to Transfer Listing to The Nasdaq Capital Market Effective May 15, 2026 - TradingView
Profusa (Nasdaq: PFSA) shifts stock listing to Nasdaq Capital Market tier - Stock Titan
Profusa moves to Nasdaq Capital Market amid compliance efforts By Investing.com - Investing.com Australia
Profusa moves to Nasdaq Capital Market amid compliance efforts - Investing.com
Profusa Announces Listing Transfer to The Nasdaq Capital Market - The Manila Times
Profusa announces listing transfer to the Nasdaq Capital Market - marketscreener.com
Digital health company Profusa shifts Nasdaq tier to meet listing rules - Stock Titan
Profusa granted transfer to Nasdaq Capital Market, faces July compliance deadline - MSN
Profusa announces initial $1 million bitcoin investment to initiate its digital asset treasury strategy - MSN
Profusa (NASDAQ: PFSA) seeks vote on reverse split, $30M Bio Insights deal - Stock Titan
Number of shareholders of PROFUSA, INC. – OTC:NVACW - TradingView
NVACW | PROFUSA INC WTS Insider Trading - Quiver Quantitative
Profusa Granted Conditional Nasdaq Listing Extension and Transfer - TipRanks
Profusa Receives Favorable Nasdaq Listing Determination - The Manila Times
Profusa, Inc. Granted Transfer to Nasdaq Capital Market Amid Compliance Efforts - Quiver Quantitative
Conditional Nasdaq listing relief for Profusa (NASDAQ: PFSA) - Stock Titan
Profusa keeps Nasdaq listing if it meets July 6 price and equity rules - Stock Titan
Profusa Secures New Convertible Note and Warrant Financing - TipRanks
Profusa (PFSA) insider-linked LLC converts $1.87M note into 5.34M shares - Stock Titan
Profusa (PFSA) CFO-linked LLC converts $1,869,796 note into 5.34M shares - Stock Titan
Profusa initiates strategic review, focuses on European approval By Investing.com - Investing.com Australia
Profusa initiates strategic review, focuses on European approval - Investing.com
Profusa Inc Profusa initiates board-led process to evaluate strategic alternatives and maximize shareholder value - marketscreener.com
Profusa Inc Profusa Initiates Board-Led Process To Evaluate Strategic Alternatives And Maximize Shareholder Value - TradingView
Profusa Inc (PFSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
1.94%
자본화:
|
볼륨(24시간):